Pulmonary and Intestinal Involvement in a Patient with Myeloperoxidase-specific Antineutrophil Cytoplasmic Antibody-positive Hermansky-Pudlak Syndrome

Intern Med. 2023 Jan 1;62(1):103-106. doi: 10.2169/internalmedicine.9350-22. Epub 2022 Jun 7.

Abstract

A 26-year-old Japanese woman was admitted with a 1-month history of diarrhea, a high fever for a few days, and exacerbation of dyspnea. She was treated with an antifibrotic drug and long-term oxygen therapy for Hermansky-Pudlak syndrome-related pulmonary fibrosis. New ground-glass attenuation appeared on chest computed tomography (CT), and a colon biopsy showed an inflammatory cell accumulation with a high titer of myeloperoxidase (MPO)-specific anti-neutrophil cytoplasmic antibodies (ANCA). Systemic inflammation related to MPO-ANCA titer elevation was suspected. Steroid pulse therapy and intravenous cyclophosphamide improved chest CT findings and diarrhea. Therefore, immunosuppressant treatment should be considered for systemic inflammation related to MPO-ANCA.

Keywords: Hermansky-Pudlak syndrome; MPO-ANCA; granulomatous colitis; pulmonary fibrosis; steroid pulse treatment; vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Antineutrophil Cytoplasmic*
  • Diarrhea
  • Female
  • Hermanski-Pudlak Syndrome* / complications
  • Hermanski-Pudlak Syndrome* / diagnosis
  • Humans
  • Inflammation
  • Peroxidase

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Peroxidase